Letko, Brosseau & Associates Inc Profound Medical Corp. Transaction History

Letko, Brosseau & Associates Inc

  • $5.53 Billion
  • Q3 2025

A detailed history of Letko, Brosseau & Associates Inc transactions in Profound Medical Corp. stock. As of the latest transaction made, Letko, Brosseau & Associates Inc holds 986,250 shares of PROF stock, worth $6.58 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
986,250
Previous 1,204,250 18.1%
Holding current value
$6.58 Million
Previous $7.11 Million 29.77%
% of portfolio
0.09%
Previous 0.14%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
SELL
$3.87 - $6.13 $843,660 - $1.34 Million
-218,000 Reduced 18.1%
986,250 $4.99 Million
Q2 2025

Aug 08, 2025
SELL
$4.04 - $6.86 $14,544 - $24,696
-3,600 Reduced 0.3%
1,204,250 $7.11 Million
Q1 2025

May 08, 2025
SELL
$5.81 - $7.9 $19,173 - $26,070
-3,300 Reduced 0.27%
1,207,850 $7.03 Million
Q4 2024

Feb 14, 2025
BUY
$6.98 - $8.96 $86,377 - $110,880
12,375 Added 1.03%
1,211,150 $9.1 Million
Q2 2024

Aug 06, 2024
SELL
$7.25 - $9.07 $236,712 - $296,135
-32,650 Reduced 2.65%
1,198,775 $10.1 Million
Q1 2024

May 08, 2024
BUY
$7.3 - $9.46 $391,097 - $506,819
53,575 Added 4.55%
1,231,425 $10.5 Million
Q4 2023

Feb 12, 2024
BUY
$7.85 - $11.18 $107,741 - $153,445
13,725 Added 1.18%
1,177,850 $10 Million
Q3 2023

Nov 09, 2023
SELL
$7.91 - $13.27 $32,826 - $55,070
-4,150 Reduced 0.36%
1,164,125 $11.9 Million
Q2 2023

Aug 10, 2023
SELL
$9.27 - $14.88 $32,445 - $52,080
-3,500 Reduced 0.3%
1,168,275 $15.2 Million
Q1 2023

May 11, 2023
SELL
$8.85 - $13.27 $76,552 - $114,785
-8,650 Reduced 0.73%
1,171,775 $10.9 Million
Q4 2022

Feb 10, 2023
SELL
$3.18 - $10.91 $239,295 - $820,977
-75,250 Reduced 5.99%
1,180,425 $12.6 Million
Q3 2022

Nov 10, 2022
BUY
$3.99 - $9.3 $2,593 - $6,045
650 Added 0.05%
1,255,675 $5.01 Million
Q2 2022

Aug 09, 2022
SELL
$6.34 - $9.53 $279,594 - $420,273
-44,100 Reduced 3.39%
1,255,025 $8.89 Million
Q1 2022

May 11, 2022
BUY
$8.16 - $11.33 $3.89 Million - $5.4 Million
476,875 Added 58.0%
1,299,125 $11.7 Million
Q4 2021

Feb 09, 2022
BUY
$10.38 - $15.2 $44,374 - $64,980
4,275 Added 0.52%
822,250 $9.28 Million
Q3 2021

Nov 03, 2021
BUY
$13.6 - $17.88 $93,840 - $123,372
6,900 Added 0.85%
817,975 $11.9 Million
Q2 2021

Jul 29, 2021
SELL
$16.0 - $20.59 $141,200 - $181,706
-8,825 Reduced 1.08%
811,075 $13.2 Million
Q1 2021

May 11, 2021
SELL
$19.16 - $28.09 $379,368 - $556,182
-19,800 Reduced 2.36%
819,900 $16.4 Million
Q4 2020

Feb 05, 2021
BUY
$16.4 - $22.9 $13 Million - $18.2 Million
793,700 Added 1725.43%
839,700 $17.3 Million
Q3 2020

Nov 09, 2020
BUY
$14.05 - $18.13 $646,300 - $833,980
46,000 New
46,000 $811,000

Others Institutions Holding PROF

# of Institutions
45
Shares Held
11.2M
Call Options Held
0
Put Options Held
0
View Full List

About Profound Medical Corp.

PROF Quotes by TradingView
  • Ticker PROF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,851,300
  • Market Cap $139M
  • Description
  • Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...
More about PROF
Track This Portfolio

Track Letko, Brosseau & Associates Inc Portfolio

Follow Letko, Brosseau & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Letko, Brosseau & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Letko, Brosseau & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email